References
- Richardson TE, Kumar A, Xing C, et al. Overcoming the odds: toward a molecular profile of long-term survival in glioblastoma. J Neuropathol Exp Neurol. 2020;79:1031–1037.
- Youngblood MW, Stupp R, Sonabend AM. Role of resection in glioblastoma management. Neurosurg Clin N Am. 2021;32:9–22.
- Helson L, Majeed M. Pleiotropic chemotherapy to abrogate glioblastoma multiforme migration/invasion. Anticancer Res. 2019;39:3423–3427.
- Cox TR. The matrix in cancer. Nat Rev Cancer. 2021;21:217–238.
- Yan Z, Wang S. Proteoglycans as therapeutic targets in brain cancer. Front Oncol. 2020;10:1358.
- Grunwell JR, Bertozzi CR. Carbohydrate sulfotransferases of the GalNAc/Gal/GlcNAc6ST family. Biochemistry. 2002;41:13117–13126.
- Bowman KG, Bertozzi CR. Carbohydrate sulfotransferases: mediators of extracellular communication. Chem Biol. 1999;6:R9–R22.
- Zhou H, Li Y, Song X, et al. CHST11/13 regulate the metastasis and chemosensitivity of human hepatocellular carcinoma cells via mitogen-activated protein kinase pathway. Dig Dis Sci. 2016;61:1972–1985.
- Debeljak Ž, Dundović S, Badovinac S, et al. Serum carbohydrate sulfotransferase 7 in lung cancer and non-malignant pulmonary inflammations. Clin Chem Lab Med. 2018;56:1328–1335.
- Matsuda Y, Fujii Y, Matsukawa M, et al. Overexpression of carbohydrate sulfotransferase 15 in pancreatic cancer stroma is associated with worse prognosis. Oncol Lett. 2019;18:4100–4105.
- Oliveira-Ferrer L, Heßling A, Trillsch F, et al. Prognostic impact of chondroitin-4-sulfotransferase CHST11 in ovarian cancer. Tumour Biol. 2015;36:9023–9030.
- Cooney CA, Jousheghany F, Yao-Borengasser A, et al. Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Res. 2011;13:R58.
- Subbarayan K, Seliger B. Tumor-dependent effects of proteoglycans and various glycosaminoglycan synthesizing enzymes and sulfotransferases on patients’ outcome. Curr Cancer Drug Targets. 2019;19:210–221.
- Pan H, Xue W, Zhao W, et al. Expression and function of chondroitin 4-sulfate and chondroitin 6-sulfate in human glioma. FASEB J. 2020;34:2853–2868.
- Blum A, Wang P, Zenklusen JC. SnapShot: TCGA-analyzed tumors. Cell. 2018;173:530.
- Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98–W102.
- Burgess DJ. Reaching completion for GTEx. Nat Rev Genet. 2020;21:717.
- Yan W, Zhang W, You G, et al. Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese glioma Cooperative Group. Neuro Oncol. 2012;14:1432–1440.
- van Tellingen O, Yetkin-Arik B, de Gooijer MC, et al. Overcoming the blood–brain tumor barrier for effective glioblastoma treatment. Drug Resist Updat. 2015;19:1–12.
- Nakayama F, Umeda S, Ichimiya T, et al. Sulfation of keratan sulfate proteoglycan reduces radiation-induced apoptosis in human Burkitt’s lymphoma cell lines. FEBS Lett. 2013;587:231–237.
- Zhang L, Fan Y, Wang X, et al. Carbohydrate sulfotransferase 4 inhibits the progression of hepatitis B virus-related hepatocellular carcinoma and is a potential prognostic marker in several tumors. Front Oncol. 2020;10:554331.
- Hiraoka N, Nakagawa H, Ong E, et al. Molecular cloning and expression of two distinct human chondroitin 4-O-sulfotransferases that belong to the HNK-1 sulfotransferase gene family. J Biol Chem. 2000;275:20188–20196.
- Guo Y, Zhou Y, Yan S, et al. Decreased expression of CHST-12, CHST-13, and UST in the proximal interphalangeal joint cartilage of school-age children with Kashin–Beck disease: an endemic osteoarthritis in China caused by selenium deficiency. Biol Trace Elem Res. 2019;191:276–285.
- Han J, Li D, Qu C, et al. Altered expression of chondroitin sulfate structure modifying sulfotransferases in the articular cartilage from adult osteoarthritis and Kashin–Beck disease. Osteoarthritis Cartilage. 2017;25:1372–1375.
- Coit P, Renauer P, Jeffries MA, et al. Renal involvement in lupus is characterized by unique DNA methylation changes in naive CD4+ T cells. J Autoimmun. 2015;61:29–35.
- Disanto G, Kjetil Sandve G, Ricigliano VA, et al. DNase hypersensitive sites and association with multiple sclerosis. Hum Mol Genet. 2014;23:942–948.
- Eskilsson E, Røsland GV, Solecki G, et al. EGFR heterogeneity and implications for therapeutic intervention in glioblastoma. Neuro Oncol. 2018;20:743–752.
- Armocida D, Frati A, Salvati M, et al. Is Ki-67 index overexpression in IDH wild type glioblastoma a predictor of shorter Progression Free survival? A clinical and Molecular analytic investigation. Clin Neurol Neurosurg. 2020;198:106126.
- Sasmita AO, Wong YP, Ling APK. Biomarkers and therapeutic advances in glioblastoma multiforme. Asia Pac J Clin Oncol. 2018;14:40–51.
- Shahcheraghi SH, Tchokonte-Nana V, Lotfi M, et al. Wnt/beta-catenin and PI3K/Akt/mTOR signaling pathways in glioblastoma: two main targets for drug design: a review. Curr Pharm Des. 2020;26:1729–1741.
- Osuka S, Zhu D, Zhang Z, et al. N-cadherin upregulation mediates adaptive radioresistance in glioblastoma. J Clin Invest. 2021;131:e136098.
- Li C, Yang J, Wang W, et al. LHPP exerts a tumor-inhibiting role in glioblastoma via the downregulation of Akt and Wnt/beta-catenin signaling. J Bioenerg Biomembr. 2021;53:61–71.